QuantLogix ← EMR scorecard
📅 EMR Earnings Preview
EMR
Next report (est.)
11/02/2026
Countdown
6 days
EPS growth YoY
+23.1%
Revenue growth YoY
+7.0%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/04/2026 ±3.0% +2.6% over-priced
05/05/2026 ±2.7% +2.2% over-priced
02/03/2026 ±2.3% +2.3% under-priced
11/10/2025 ±3.3% +0.4% over-priced
08/06/2025 ±2.2% -4.7% under-priced
05/07/2025 ±2.4% +2.4% over-priced
02/05/2025 ±2.1% -2.3% under-priced
11/12/2024 ±4.5% -0.6% over-priced
Across these reports, options implied an average ±2.8% move vs an actual average of 2.2% — the stock stayed inside the implied band 63% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q3 FY2026 $1.28 $4.9B $718M
Q2 FY2026 — $4.6B $618M
Q1 FY2026 $1.07 $4.3B $605M
Q4 FY2025 $1.12 $4.9B $637M
Analyst posture
Buy / Strong Buy
24
Hold
10
Sell
1
Stable: +1 net change 30d
Live 5-factor engine read: Neutral · 49/100 Full scorecard →
Get alerted before every EMR report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on EMR before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

EMR (EMR) reports in 6 days, with the next report estimated for 11/02/2026. Across the last 8 reports, options priced an average ±2.8% earnings move while the stock actually moved 2.2% on average — the market has been roughly fair on EMR's earnings risk. Fundamentals into the print: EPS up 23.1% year-over-year, revenue up 7.0%. QuantLogix's live 5-factor engine currently reads EMR as a neutral at 49/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →